Great Basin Scientific, Inc./ US39013L8827 /
4/23/2020 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0150USD | - | 5,281 Turnover: - |
-Bid Size: - | -Ask Size: - | 0.0290 | 0.0050 |
GlobeNewswire
7/4/2019
Global Syndromic Multiplex Diagnostic Market to 2023 - POC Testing & Molecular Diagnostics are Mergi...
GlobeNewswire
4/16/2019
Global Syndromic Multiplex Diagnostic Markets 2019 to 2023 - Strategies and Trends, Forecasts by Syn...
GlobeNewswire
8/29/2018
Global Syndromic Multiplex Diagnostic Markets, Strategies and Trends 2019-2023
GlobeNewswire
7/11/2018
Global Clinical Laboratory Services Strategic Business Report 2018 - Standardization Gains Precedenc...
GlobeNewswire
7/13/2017
Great Basin Scientific Receives FDA 510(k) Clearance for Stool Bacterial Pathogens Panel
GlobeNewswire
6/1/2017
Data to be Presented at ASM Microbe 2017 Demonstrates the Efficacy of Great Basin’s Stool Bacterial ...
GlobeNewswire
5/24/2017
Great Basin Scientific Issued Second U.S. Patent for PCR Amplification Suppressor
GlobeNewswire
5/16/2017
Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test
GlobeNewswire
5/15/2017
Great Basin Scientific Obtains Release of $1.36 Million of Restricted Cash from Series B Convertible...
GlobeNewswire
4/17/2017
Great Basin Scientific Announces Completion of Restructuring of Convertible Notes
GlobeNewswire
4/12/2017
Great Basin Scientific Receives CE Marking for Stool Bacterial Pathogens Panel
GlobeNewswire
4/7/2017
Great Basin Scientific Announces Date of Effectiveness of Reverse Stock Split
GlobeNewswire
4/6/2017
Study Published in PLOS ONE Demonstrates Effectiveness of Great Basin Scientific’s Patented Amplific...
GlobeNewswire
4/3/2017
Great Basin Scientific Receives FDA 510(k) Clearance for Bordetella Direct Test
GlobeNewswire
3/10/2017
Great Basin Scientific Receives Stockholder Approval for Reverse Stock Split and Authorized Share In...